Skip to main content
SpringerLink
Log in
Book cover

Bone Metastases pp 187–205Cite as

Isotope Therapy For Bone Metastases

  • Chapter

Abstract

Therapy using radioactive labelled tracer molecules is at present an area of considerable interest and research. The principle of using a tracer molecule to target radiotherapy to a tumour has been well established with the use of iodine-131 in the treatment of follicular thyroid cancer and phosphorus-32 to treat polycythaemia rubra vera (Seidlin et al. 1946; O’Mara 1978).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allen SJ, Blake GM, McKeeney DB, Lazarus CR, Blower P, Singh J, Page C, Clarke SEM (1990) Rh-186-v-DMSA: dosimetry of a new radiopharmaceutical for therapy of medullary carcinoma of the thyroid. Nucl Med Commun 11:220–221

    Google Scholar 

  • Andres R, Blattman H, Pfeiffer G, Schubiger PA, Vogt M, Weinreich R, Wernli C (1986) Radionuclides for therapy: a review. In: Schubiger P, Hasler PH (eds) Radionuclides for therapy. Proceedings of the 4th Bottstein Colloquium. Hoffman la Roche, Basle, pp 9–20

    Google Scholar 

  • Baulieu JL, Guilloteau D, Baulieu F, Le Floch O, Chambon C, Pourcelot L, Besnard JL (1988) Therapeutic effectiveness of Iodine-131 MIBG for metastases of a non-secreting paraganglioma. J Nucl Med 29:2008–2013

    PubMed  CAS  Google Scholar 

  • Beer HF, Blauenstein P, Andres R, Hasler PH, Schubiger P (1986) How to get the radionuclide to the right site. In Schubiger P, Hasler PH (eds) Radionuclides for therapy, Proc of 4th Bottstein Colloquium. Hoffman la Roche, Basle, pp 60–74

    Google Scholar 

  • Blake G (1986) Strontium-89 therapy: strontium kinetics in disseminated carcinoma of the prostate. Eur J Nucl Med 12:447–454

    PubMed  CAS  Google Scholar 

  • Blake GM, Zivanovic MA, Blaquere RM, Fine DR, McEwan EJ, Ackery DM (1988) Sr-89 therapy -measurement of observed dose to skeletal metastases. J Nucl Med 29:549–557

    PubMed  CAS  Google Scholar 

  • Blower PJ, Clarke SEM, Bisuriadan MM, Singh J, West MJ (1990) Preparation and characterisation of pentavalent Rh-186 DMSA. A possible tumour therapy agent. Nucl Med Commun 11: 212–213

    Article  Google Scholar 

  • Boniface G, Izard M, Walker K, McKay D, Sorby P, Harvey Turner J, Morris J (1989) Labelling of monoclonal antibodies with Sm-153 for combined radioimmunoscintigraphy and radioimmunotherapy. J Nucl Med 30:683–691

    PubMed  CAS  Google Scholar 

  • Bowen BM, Darracott J, Garnett ES, Tomlinson RH (1975) Yttrium-90 citrate colloid for radioisotope synovectomy. Am J Hosp Pharm 32:1027–1030

    PubMed  CAS  Google Scholar 

  • Carichner S, Eary J, Collins C, Nemiroff K, Richter D, Lewis D, Applebaum F (1989) Samarium-153 EDTMP. Technical aspects of imaging and treatment. Clin Nucl Med 14:B1,11

    Article  Google Scholar 

  • Carrelta R, Martin P, Malekian T (1989) Strontium-89 therapy for metastatic prostate and breast carcinoma: a community hospital experience. Clin Nucl Med 14:A5, 11

    Article  Google Scholar 

  • Charbord P, L’heritier C, Cukerstein W, Lumbroso J, Tubiana M (1977) Radio-iodine treatment in differentiated thyroid carcinomas. Treatment of first local recurrences and of bone and lung metastases. Ann Radiol 20:783–786

    PubMed  CAS  Google Scholar 

  • Clarke SEM, Lazarus CR, Edwards S, Murby B, Clarke DG, Roden T, Fogelman I, Maisey MN (1987) Scintigraphy and treatment of MCT with 131I-MIBG. J Nucl Med 28:1820

    PubMed  CAS  Google Scholar 

  • Dunscombe PB, Ramsey NW (1980) Radioactivity studies on two synovectomy specimens after radiation synovectomy with Yttrium-90-silicate. Ann Rheum Dis 39:87–89

    Article  PubMed  CAS  Google Scholar 

  • Ehrlich P (1906) Collected studies of immunity. John Wiley and Sons, Chichester

    Google Scholar 

  • Ehrlich P (1960) The collected papers of Paul Ehrlich. Pergamon Press, New York, pp 505–518

    Google Scholar 

  • Fischer M, Kamanabroo D, Sonderkarys H (1984) Scintigraphic imaging of carcinoid tumours with 131I-MIBG. Lancet ii: 165

    Google Scholar 

  • Fisher DR (1985) The microdosimetry of monoclonal antibodies labelled with alpha particles. Fourth International Radiopharmaceutical Symposium. CONF -851113, 446–457, Oakridge, Tennessee

    Google Scholar 

  • Francis MD, Slough CL, Tofe AJ (1976) Distribution and effect of P32 EHDP in normal and bone tumour bearing dogs. J Nucl Med 17:548

    Google Scholar 

  • Goodhead DT (1985) Saturable repair models of radiation action in mammalian cells. Radiat Res 104.S58–S67

    Article  CAS  Google Scholar 

  • Goodwin D, Meares C, Diamonti C, McCall M, Lai C, Torti F, McTigue M, Martin B (1990) Use of specific antibody for rapid clearance of circulating blood background from tumour imaging proteins. Eur J Nucl Med 9:209–215

    Article  Google Scholar 

  • Gorckler WF, Edwards B, Volkert WA (1987) Skeletal localisation of Sm-153 chelates, potential therapeutic bone agents. J Nucl Med 28:495–504

    Google Scholar 

  • Griffiths MH, York ED, Wessels BW, Denardo GL, Neacy WP (1988) Direct dose confirmation of quantitative autoradiography with micro TLD measurements for radioimmunotherapy. J Nucl Med 29:1795–1809

    Google Scholar 

  • Hall N, Tokars RP, O’Mara RE (1975) P32 diphosphonate: a potential therapeutic agent. J Nucl Med 16:532

    Google Scholar 

  • Harvey Turner J, Martindale A, Sorby P, Hetherington E, Fleay R, Hoffman R, Caringbold P (1989) Samarium-153 EDTMP therapy of disseminated skeletal metastases. Eur J Nucl Med 15:784–795

    Google Scholar 

  • Hill JM, Lobe E, Spear RJ (1962) IV colloidal zirconyl phosphate P-32. Clinical studies of over 250 cases. J Nucl Med 3:196

    Google Scholar 

  • Hisada K, Ando (1973) Radiolanthides as promising tumour scanning agents. J Nucl Med 14:615–617

    PubMed  CAS  Google Scholar 

  • Hoefnagel CA (1989) The clinical use of 131I metaiodobenzylguanidine for the diagnosis and treatment of neural crest tumours. Academisch Proef Schrift

    Google Scholar 

  • Hoefnagel CA, DeKraker J, Marcuse HR, Voute PA (1986) Detection and treatment of neural crest tumours using 131I-MIBG. In: Schmidt HAE, Ell PJ, Britton KE (eds) Nuklearmedizin -nuclear medicine in research and practice. Schattauer Verlag, Stuttgart, pp 473–476

    Google Scholar 

  • Hoefnagel CA, Voute PA, DeKraker J, Marcuse HR (1987) Radionuclide diagnosis and therapy of neural crest tumours using iodine-131 MIBG. J Nucl Med 28:308–314

    PubMed  CAS  Google Scholar 

  • Humm JL, Cobb LM (1990) Non-uniformity of tumour dose in radioimmunotherapy. J Nucl Med 31:75–83

    PubMed  CAS  Google Scholar 

  • Ketring A (1987) Sm-153-EHDP and rhenium-186 HEDP as bone therapeutic radiopharmaceuticals. Int J Rad Appl Instrum [B] 14:223–232

    Article  CAS  Google Scholar 

  • Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–496

    Article  PubMed  Google Scholar 

  • Larsen SM, Carrasquillo JA, Krohn KA, Brown JP, McGuffin RW, Ferens JM, Graham MM, Hill LD, Beaumier PL, Helstrom KE, Helstrom I (1983) Localization of 131I labelled P97 specific Fab fragments in human melanoma as a basis for radiotherapy. J Clin Invest 72:2101–2114

    Article  Google Scholar 

  • Lewington VJ, Zivanovic MA, Blake GB, Buchanan RB, Akery DM (1988) Treatment of bone pain in disseminated prostatic cancer using strontium-89. Nucl Med Commun 9:179–186 (abstr)

    Google Scholar 

  • Marchandise X, Brendel AJ, Caudry M, Charbonnel B, Chatal JF, Lanheche B, Lumsioso J, Marnex R, Schlumberger M, Werneaun JL (1985) Treatment of malignant phaeochromocytomas with 1–131 MIBG. Results of a French multicenter study. Nucl Med 26:51–52

    Google Scholar 

  • McCardle RJ, Harper P, Spar I, Bale W, Andros G, Jiminez F (1966) Studies with 131I-labeled antibody to human fibrinogen for diagnosis and therapy of tumours. J Nucl Med 7:837–847

    PubMed  CAS  Google Scholar 

  • McEwan AJ, Catz A, Fields AL, Lewington V, Harbara D, Fine D, Ackery DM (1987) 131I-MIBG in the diagnosis and treatment of carcinoid syndrome. J Nucl Med 28:658

    Google Scholar 

  • Milstein C (1980) Monoclonal antibodies. Sci Am 243:66–74

    Article  PubMed  CAS  Google Scholar 

  • O’Mara RE (1978) In: RP Spencer (ed) Therapy in nuclear medicine. Grune and Stratton, New York, p 257

    Google Scholar 

  • Pecker C (1942) Biological investigations with radioactive calcium and strontium: preliminary report on the use of radioactive strontium in the treatment of metastatic bone cancer. Pharmacology, 1:117–139

    Google Scholar 

  • Peng TX, Moya A, Ayala FJ (1986) Irradiation resistance conferred by super oxide dismutase: possible adaptive role of a natural polymorphism in Drosophila melanogaster. Proc Natl Acad Sci USA 83:684–687

    Article  PubMed  CAS  Google Scholar 

  • Pochin EE (1967). Prospects from the treatment of thyroid carcinoma with radio-iodine. Clin Radiol 18:113–125

    Article  PubMed  CAS  Google Scholar 

  • Pochin EE (1969) Long term hazards of radio-iodine treatment of thyroid carcinoma. In: Hedinger CE (ed). Thyroid cancer. UICC Monograph Series, vol 12. Springer Verlag, Berlin Heidelberg New York p 293

    Google Scholar 

  • Poston GJ, Thomas H, MacDonald DW, Lynn JA, Lavender JP (1985) 13II-MIBG uptake by medullary carcinoma of the thyroid. Lancet ii:560

    Google Scholar 

  • Potsaid M, Irwin F, Castronovo G, Prout G, Harvey W, Francis M, Tofe A (1976) Phophorus-32 EHDP clinical study of patients with prostatic carcinoma bone metastases. J Nucl Med 17:548

    Google Scholar 

  • Robinson R, Spicer JA, Preston DF, Wegst AV, Martin NL (1987) Treatment of metastatic bone pain with strontium-89. Nucl Med Biol 14:219–222

    CAS  Google Scholar 

  • Seeman G, Bosslet K, Sedlacek HA (1987) Human anti-tumour antibodies: problems, opportunities, immunotherapy and scintigraphy of tumours with monoclonal antibodies. Aktuel Onkol 41:21–25

    Google Scholar 

  • Seidlin SM, Marinelle LD, Oshry E (1946) Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroid. JAMA 132:838

    Article  CAS  Google Scholar 

  • Shapiro B, Sisson JC, Lloyd R, Nakajo M, Satterlee W, Bierwalters WH (1984) Malignant phaeochromocytoma: clinical, biochemical and scintigraphic characterisation. Clin Endocrinol 20:189–203

    Article  CAS  Google Scholar 

  • Shapiro B, Andrews J, Figg L, Carey J, Walker-Andrews S, Smith J, Ensminger W (1989) Therapeutic intraarterial administration of yttrium-90 glass microspheres for hepatic tumours. Eur J Nucl Med 8:401

    Google Scholar 

  • Shaw DR, Khazaeli MB, Lobuglio AF (1988) Mouse/human chimeric antibodies to a tumour associated antigen; biological activity of the four human IgG subclasses. J Natl Cancer Inst 80:1553–1559

    Article  PubMed  CAS  Google Scholar 

  • Stewart JSW, Griffiths M, Munro AJ, Lambert JO, Coutter C, Epenetos A (1987) Intraperitoneal radioimmunotherapy for ovarian cancer. Aktuel Onkol 41:65–73

    Google Scholar 

  • Todd P, Wood JCS, Walker JT, Weiss St J (1985) Lethal, potential lethal and non-lethal damage induction by heavy ions in cultured human cells. Radiat Res 104:S5–S12

    Article  CAS  Google Scholar 

  • Tubiana M, Lacour T, Marnier J, Bergiron C, Gerard Marchant R, Roujean J, Bok B, Parmentier C (1975) External radiotherapy and radio-iodine in the treatment of 359 thyroid cancers. Br J Radiol 49:894–907

    Article  Google Scholar 

  • Van Gils APG, Van Der May AGL, Hoogma RPJM, Falke TITM, Moolenaar AJ, Pauwels EKJ, Van Kroonen Burgh MJPG (1989) Iodium-123 MIBG scintigrafie bij chemodactomen een oprallend resultaat. Nucl Geneeskd Bull 11:61

    Google Scholar 

  • Wieland DM, Brown LE, Mangner TJ, Swanscombe DP, Bierwaters W (1980) Radiolabeled adrenergic neuro blocking agents: Adreno-medullary imaging with 131I-iodobenzylguanidine. J Nucl Med 21:349–353

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Susan E. M. Clarke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Imperial Cancer Research Fund Clinical Oncology Unit, United Medical and Dental Schools of Guy’s and St Thomas’s Hospitals, Guy’s Hospital, London, SE1 9RT, UK

    R. D. Rubens BSc, MD, FRCP (Professor) (Professor)

  2. Department of Nuclear Medicine, Guy’s Hospital, London, SE1 9RT, UK

    I. Fogelman BSc, MD, FRCP (Consultant Physician) (Consultant Physician)

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag London Limited

About this chapter

Cite this chapter

Clarke, S.E.M. (1991). Isotope Therapy For Bone Metastases. In: Rubens, R.D., Fogelman, I. (eds) Bone Metastases. Springer, London. https://doi.org/10.1007/978-1-4471-3254-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3254-7_10

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-3256-1

  • Online ISBN: 978-1-4471-3254-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation